Effect of teriparatide (rh-PTH 1–34) versus bisphosphonate on the healing of osteoporotic vertebral compression fracture: A retrospective comparative study

BACKGROUND: Teriparatide (recombinant human parathyroid hormone 1–34) is increasingly used for the treatment of severe osteoporosis because it stimulates bone formation and may potentially enhance fracture healing. The objective of this study was to investigate the effects of teriparatide versus a b...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Musculoskelet Disord
Hlavní autoři: Iwata, Akira, Kanayama, Masahiro, Oha, Fumihiro, Hashimoto, Tomoyuki, Iwasaki, Norimasa
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5384154/
https://ncbi.nlm.nih.gov/pubmed/28388910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-017-1509-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky